Muscle Cell Mediated Therapy for Tongue Dysphagia: An Investigation of Cook MyoSite Autologous Muscle Derived Cells
Phase of Trial: Phase I
Latest Information Update: 19 Jun 2017
At a glance
- Drugs Autologous muscle-derived stem cell therapy Cook MyoSite (Primary)
- Indications Oropharyngeal cancer; Squamous cell cancer
- Focus Adverse reactions
- 13 Jun 2017 Status changed from not yet recruiting to recruiting.
- 25 May 2017 Planned initiation date changed from 1 Sep 2016 to 1 Jun 2017.
- 01 Aug 2016 New trial record